Literature DB >> 10514508

Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse Osteocalcin promoters.

T Schinke1, G Karsenty.   

Abstract

To elucidate the mechanisms of osteoblast-specific gene expression we are studying the regulation of osteocalcin, the most osteoblast-specific gene. Previous studies of OG2, one of the two mouse osteocalcin genes, identified two osteoblast-specific cis-acting elements, OSE1 and OSE2, the latter being the binding site of Cbfa1, the only osteoblast-specific transcription factor known to date. Here we show that OSE1 is a cis-acting element as important as OSE2 for the osteoblast-specific expression of OG2 in cell culture and transgenic mice. We also show that OSE1 is present in the promoter of several osteoblast-specific genes including Cbfa1 itself. These biological features demonstrate the importance of OSE1 and led us to further characterize this site and the factor binding to it, provisionally termed Osf1. We first defined the core OSE1 sequence, 5'-TTACATCA-3', which is necessary and sufficient for Osf1 binding to DNA. This sequence has no strong homology to any known transcription factor-binding sites. As a first step in identifying Osf1, we performed an analytical purification of this protein using nuclear extracts from two different osteoblastic cell lines. We purified Osf1 to homogeneity through a five-step procedure including a renaturation experiment and found that its apparent molecular mass is 40 kDa. In conclusion, this study indicates the existence of multiple osteoblast-specific cis-acting elements of equal importance in controlling OG2 promoter activity and provides the first biochemical characterization of Osf1, a novel osteoblast-specific transcription factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514508     DOI: 10.1074/jbc.274.42.30182

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  The loss of activating transcription factor 4 (ATF4) reduces bone toughness and fracture toughness.

Authors:  Alexander J Makowski; Sasidhar Uppuganti; Sandra A Wadeer; Jack M Whitehead; Barbara J Rowland; Mathilde Granke; Anita Mahadevan-Jansen; Xiangli Yang; Jeffry S Nyman
Journal:  Bone       Date:  2014-02-07       Impact factor: 4.398

3.  Chondrocytic Atf4 regulates osteoblast differentiation and function via Ihh.

Authors:  Weiguang Wang; Na Lian; Yun Ma; Lingzhen Li; Richard C Gallant; Florent Elefteriou; Xiangli Yang
Journal:  Development       Date:  2011-12-21       Impact factor: 6.868

4.  Hop2 Interacts with ATF4 to Promote Osteoblast Differentiation.

Authors:  Yang Zhang; Tonghui Lin; Na Lian; Huan Tao; Cong Li; Lingzhen Li; Xiangli Yang
Journal:  J Bone Miner Res       Date:  2019-11-04       Impact factor: 6.741

5.  Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.

Authors:  Xue-Bin Wu; Yanan Li; Adina Schneider; Wanqin Yu; Gopalan Rajendren; Jameel Iqbal; Matsuo Yamamoto; Mohammad Alam; Lisa J Brunet; Harry C Blair; Mone Zaidi; Etsuko Abe
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription.

Authors:  Weiguang Wang; Na Lian; Lingzhen Li; Heather E Moss; Weixi Wang; Daniel S Perrien; Florent Elefteriou; Xiangli Yang
Journal:  Development       Date:  2009-11-11       Impact factor: 6.868

7.  Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.

Authors:  Jochen Schulze; Sebastian Seitz; Hiroaki Saito; Michael Schneebauer; Robert P Marshall; Anke Baranowsky; Bjoern Busse; Arndt F Schilling; Felix W Friedrich; Joachim Albers; Alexander S Spiro; Jozef Zustin; Thomas Streichert; Kristina Ellwanger; Christof Niehrs; Michael Amling; Roland Baron; Thorsten Schinke
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

8.  FIAT represses bone matrix mineralization by interacting with ATF4 through its second leucine zipper.

Authors:  Vionnie W C Yu; Claude Gauthier; René St-Arnaud
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

9.  Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Authors:  Na Lian; Tonghui Lin; Wenguang Liu; Weiguang Wang; Lingzhen Li; Stephanie Sun; Jeffry S Nyman; Xiangli Yang
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

10.  Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation.

Authors:  Na Lian; Weiguang Wang; Lingzhen Li; Florent Elefteriou; Xiangli Yang
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.